<DOC>
	<DOCNO>NCT02837172</DOCNO>
	<brief_summary>This project evaluate utility diffusion tensor imaging ( DTI ) adjunctive method improve early diagnosis Parkinson 's disease ( PD ) . Two population evaluate study : 1 ) Individuals uncertain PD diagnosis receive DaTscan , 2 ) individual well characterize PD healthy control , draw fully enrol Parkinson 's Progression Markers Initiative ( PPMI ) PD control cohort .</brief_summary>
	<brief_title>Diagnosis PD PD Progression Using DWI</brief_title>
	<detailed_description>Specific Aim 1a : Compare outcome DTI base prediction contemporaneous clinical DAT scan 100 subject suspect parkinsonism , determine rate concordance two diagnostic technique . Specific Aim 1b : Compare predictive accuracy baseline DTI `` gold standard '' expert diagnosis 36 month follow 100 subject receive DaTscan suspect parkinsonism . Specific Aim 2a : Use TBM evaluate volume cross-sectional caliber ( base point-wise fiber track direction ) fimbria , pallidonigral tract , subthalamic-nigral tract PD healthy control . Ascertain change white matter volume caliber use predict presence PD PPMI study . Secondarily , use model free approach , determine white matter feature base TBM predict presence disease . Specific Aim 2b : Use TBM determine increase rate change volume cross-sectional caliber fimbria , hypertrophic pallidonigral , subthalamic-nigral tract identify aim 2a , associate rapid rate disease progression PD . Secondarily , use model free approach , determine white matter feature base TBM predict faster rate disease progression 5 year course PPMI study . Specific Aim 3a : Compare DTI FA TD-PD PIGD-PD thalamus lobule IX cerebellum , study subject PPMI study . Predict signal region predict phenotypic expression disease . Using TBM bootstrapping , determine relationship phenotypic expression disease white matter input/output pathway thalamus , lobule IX cerebellum .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Patients 19 old Referred clinical DaTscan possible PD Controls PPMI dataset . Pregnant woman Participants participate MRI ( metallic artifact contraindication ( ) MRI 3T )</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>